Medication info

Fosaron Tablets (Sodium Alendronate Hydrate)

Prescription medicationTabletOralExpired
Ingredient · strength
Sodium Alendronate Hydrate›91.37mg / 1 tablet
Manufacturer / importer
Kips Biopharma Co., Ltd.
Appearance
White oval-shaped tablet
Packaging
4 tablets/AluAlu
Approval status
Expired

MFDS item code 201404691 · Approved 2014.10.13

This product's status changed to Expired on 2024.10.13. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of osteoporosis in postmenopausal women and men
Who takes it
Adults
Adult dose
Take 70 mg of alendronic acid once weekly in the morning with a sufficient amount of water, at least 30 minutes before consuming food, beverages, or other medicines (see Precautions). Other beverages or foods, including mineral water and barley tea, and medicines may reduce the absorption of this medicine (see Interactions). Consuming food within 30 minutes after taking this medicine, or at the same time, may reduce its absorption into the body and decrease its effect. Take this medicine as soon as you get up in the morning and swallow it with a sufficient amount of water (170 ∼ 230 mL) to help the medicine reach the stomach quickly and reduce the possibility of esophageal irritation. Do not lie down for at least 30 minutes after taking it and until after the first food intake. Do not take this medicine at bedtime or before getting up. Failure to follow these instructions may increase the risk of esophageal adverse reactions (see Warnings and Precautions). If the patient's intake of calcium and vitamin D from food is insufficient, supplements should be taken (see Precautions). The appropriate duration of administration has not been established. The safety and efficacy of this medicine for the treatment of osteoporosis are based on clinical data from 4 years of treatment. The need for continued treatment should be reassessed periodically in all patients receiving bisphosphonates. In patients at low risk of fracture, consider discontinuing treatment after 3 ∼ 5 years. Patients who discontinue treatment should be periodically reassessed for fracture risk. If a scheduled dose is missed, take 70 mg the next morning, resume the previously scheduled dosing day, and then continue regular once-weekly dosing. Do not take 2 tablets on the same day.

Ingredients

Manufacturer
Kips Biopharma Co., Ltd.

Efficacy & effects

Treatment of osteoporosis in postmenopausal women and men

  • Osteoporosis
View approved original text

Used for the treatment of osteoporosis which can occur in both postmenopausal women and men. This medication helps prevent fractures by increasing bone density. It is effective in maintaining healthy bones by primarily improving the condition when bones are weak.

How to take

Adult dose

Take 70 mg of alendronic acid once weekly in the morning with a sufficient amount of water, at least 30 minutes before consuming food, beverages, or other medicines (see Precautions). Other beverages or foods, including mineral water and barley tea, and medicines may reduce the absorption of this medicine (see Interactions). Consuming food within 30 minutes after taking this medicine, or at the same time, may reduce its absorption into the body and decrease its effect. Take this medicine as soon as you get up in the morning and swallow it with a sufficient amount of water (170 ∼ 230 mL) to help the medicine reach the stomach quickly and reduce the possibility of esophageal irritation. Do not lie down for at least 30 minutes after taking it and until after the first food intake. Do not take this medicine at bedtime or before getting up. Failure to follow these instructions may increase the risk of esophageal adverse reactions (see Warnings and Precautions). If the patient's intake of calcium and vitamin D from food is insufficient, supplements should be taken (see Precautions). The appropriate duration of administration has not been established. The safety and efficacy of this medicine for the treatment of osteoporosis are based on clinical data from 4 years of treatment. The need for continued treatment should be reassessed periodically in all patients receiving bisphosphonates. In patients at low risk of fracture, consider discontinuing treatment after 3 ∼ 5 years. Patients who discontinue treatment should be periodically reassessed for fracture risk. If a scheduled dose is missed, take 70 mg the next morning, resume the previously scheduled dosing day, and then continue regular once-weekly dosing. Do not take 2 tablets on the same day.

Precautions

This medication can irritate the stomach and esophagus; therefore, those with esophageal diseases or upper gastrointestinal tract diseases such as gastritis, duodenitis, or ulcers should take caution when using it. Serious esophageal problems like esophagitis or esophageal ulcers can occur during treatment; if difficulty swallowing or symptoms like pain or heartburn occur, stop taking it immediately and consult a doctor. Always take with a sufficient amount of water (170–230 mL) and do not lie down for at least 30 minutes after taking. Do not eat before or after taking the medication. Patients with mental disorders or difficulties following the dosing instructions should take this medication under medical supervision. This medication should not be administered to individuals with certain esophageal abnormalities, severe renal failure, hypocalcemia, women who are pregnant or breastfeeding, or those with specific genetic disorders. Sufficient intake of calcium and vitamin D is required during treatment, and maintaining weight-bearing exercise and a healthy lifestyle is recommended. This medication may occasionally cause muscle, joint, or bone pain; seek medical advice if symptoms are severe. Rarer serious side effects such as osteonecrosis of the jaw can occur, so any dental treatment must be discussed with a healthcare professional. If taken with other medications, avoid taking calcium supplements or antacids within 30 minutes of taking this medication, and caution is required when taking it with aspirin as gastrointestinal side effects may increase. Pregnant or breastfeeding women should not take this medication, and safety and efficacy have not been confirmed in children and adolescents under 18 years old. Elderly patients can use this medication, but some may be more sensitive, requiring careful monitoring. Overdose may result in symptoms such as hypocalcemia or gastrointestinal irritation; adhere strictly to the prescribed dosage and inform healthcare professionals of any abnormal symptoms. Store this medication out of reach of children, and avoid transferring it to another container.

Side effects

  • Esophagitis
  • esophageal ulcer
  • esophageal erosion
  • esophageal obstruction
  • esophageal perforation
  • bleeding
  • abdominal pain
  • nausea
  • dyspepsia
  • constipation
Show 32 more
  • diarrhea
  • flatulence
  • acid reflux
  • vomiting
  • dysphagia
  • abdominal distension
  • gastritis
  • musculoskeletal pain
  • muscle cramps
  • headache
  • dizziness
  • taste disturbance
  • rash
  • erythema
  • anastomotic ulcer
  • symptoms of hypocalcemia
  • peripheral edema
  • oropharyngeal ulcer
  • gastric ulcer
  • duodenal ulcer
  • osteonecrosis of the jaw
  • joint swelling
  • low-energy fracture of the femoral neck
  • itching
  • hair loss
  • mucocutaneous syndrome
  • toxic epidermal necrolysis
  • uveitis
  • scleritis
  • episcleritis
  • external auditory canal cholesteatoma
  • melena

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a tightly closed container to protect it from air and moisture. It is best to maintain the storage temperature between 15 and 30 degrees Celsius, which helps preserve the medication's effectiveness for a longer duration.

Appearance and packaging

Appearance

White oval-shaped tablet

Package unit

4 tablets/AluAlu

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.